Peer-reviewed veterinary case report
Young dog with chronic monocytic leukemia treated with toceranib
By Pérez, Mayrim L et al.·Published in Anti-cancer drugs·2013·College of Veterinary Medicine, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia.
- Species:
- dog
Plain-English summary
A young dog was diagnosed with chronic monocytic leukemia, a type of blood cancer, and was treated with a combination of toceranib, a targeted cancer medication, and prednisone, a steroid. This treatment led to a significant improvement in the dog's condition, allowing it to enter clinical remission. The use of toceranib in this case suggests it may be a promising option for treating similar cases of leukemia in dogs.
People also search for: dog leukemia treatment · toceranib for dogs · prednisone for dog cancer
Abstract
Treatment of chronic monocytic leukemia (CMoL) in dogs has traditionally consisted of hydroxyurea. The use of tyrosine kinase inhibitors has been proposed as a treatment option for dogs with CMoL but has never been reported. We report a case of CMoL in a young dog that achieved clinical remission with treatment with the tyrosine kinase inhibitor toceranib and prednisone.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23995854/